HISTAKON

HISTAKON Betahistine 8mg is used for the treatment of Ménière's disease. This condition is characterized by a triad of core symptoms which include feeling dizzy (vertigo), ringing in the ears (tinnitus), and a loss or difficulty of hearing. It also provides symptomatic relief for vertigo of peripheral origin. The mechanism involves improving blood flow in the inner ear, which helps to reduce fluid pressure, thereby alleviating the related symptoms.

HISTAKON Betahistine 8mg is used for the treatment of Ménière's disease. This condition is characterized by a triad of core symptoms which include feeling dizzy (vertigo), ringing in the ears (tinnitus), and a loss or difficulty of hearing. It also provides symptomatic relief for vertigo of peripheral origin. The mechanism involves improving blood flow in the inner ear, which helps to reduce fluid pressure, thereby alleviating the related symptoms.

HISTAKON Betahistine 16mg is used for the management of Ménière's syndrome, a disorder of the inner ear. This condition can present with a combination of symptoms including the sensation of spinning or dizziness (vertigo), ringing or buzzing in the ears (tinnitus), and progressive hearing loss. The active component is thought to function by improving blood flow within the inner ear to help relieve these debilitating symptoms.